Published in Clin Appl Thromb Hemost on October 01, 2003
Association of plasminogen activator inhibitor type 2 (PAI-2) with proteasome within endothelial cells activated with inflammatory stimuli. J Biol Chem (2011) 0.82
Variant of PAI-2 gene is associated with coronary artery disease and recurrent coronary event risk in Chinese Han population. Lipids Health Dis (2015) 0.75
Lack of association between Ser(413)/Cys polymorphism of plasminogen activator inhibitor type 2 (PAI-2) and premature coronary atherosclerotic disease. EXCLI J (2012) 0.75
Methylation of tumor suppressor genes in ovarian cancer. Exp Ther Med (2012) 1.00
Methylation profiles in breast cancer. Cancer Invest (2009) 0.93
The Ala allele at Val762Ala polymorphism in poly(ADP-ribose) polymerase-1 (PARP-1) gene is associated with a decreased risk of asthma in a Turkish population. J Asthma (2009) 0.91
Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease. Tohoku J Exp Med (2012) 0.91
p53 genotypes and haplotypes associated with risk of breast cancer. Cancer Detect Prev (2007) 0.87
Platelet function and fibrinolytic activity in patients with bronchial asthma. Clin Appl Thromb Hemost (2005) 0.83
The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease. Clin Biochem (2005) 0.82
DNA repair gene XRCC1 and XPD polymorphisms and their association with coronary artery disease risks and micronucleus frequency. Heart Vessels (2007) 0.81
Effects of atorvastatin (10 mg) on hemostatic and inflammatory parameters in hyperlipidemic patients with angiographically proven coronary artery disease. Am J Cardiol (2004) 0.81
Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients. Clin Appl Thromb Hemost (2007) 0.80
Genetic variations in tumor necrosis factor alpha, interleukin-10 genes, and migraine susceptibility. Pain Med (2011) 0.79
Effects of serum homocysteine and adiponectin levels on platelet aggregation in untreated patients with essential hypertension. J Thromb Thrombolysis (2008) 0.79
Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients. Clin Appl Thromb Hemost (2007) 0.79
p53 codon 72 polymorphism and HPV status in lung cancer. Med Sci Monit (2008) 0.79
Factor V Leiden mutation in cerebrovascular disease. Clin Appl Thromb Hemost (2005) 0.78
Toxic-dose warfarin-induced apoptosis and its enhancement by gamma ionizing radiation in leukemia K562 and HL-60 cells is not mediated by induction of oxidative stress. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.78
Expression of EMSY gene in sporadic ovarian cancer. Mol Biol Rep (2010) 0.77
Genetic alterations of the LKB1 gene in head and neck cancer. DNA Cell Biol (2010) 0.77
LKB1 mutations and their correlation with LKB1 and Rheb expression in bladder cancer. Mol Carcinog (2012) 0.77
Chromosome 9p21 rs10757278 polymorphism is associated with the risk of metabolic syndrome. Mol Cell Biochem (2013) 0.76
Preliminary study showing the relationship between platelet fibronectin, sialic acid, and ADP-induced aggregation levels in coronary heart disease. Clin Appl Thromb Hemost (2007) 0.76
Relationship between two estrogen receptor-alpha gene polymorphisms and angiographic coronary artery disease. Anadolu Kardiyol Derg (2009) 0.76
Investigation of glutathione S-transferase M1 and T1 deletions in lung cancer. Mol Biol Rep (2009) 0.76
In vivo effect of losartan on platelet aggregation in patients with hypertension. Heart Vessels (2004) 0.75
Enhanced sensitivity to oxidant-induced micronucleus frequency in elderly individuals is not associated with glutathione S-transferase M1 (GSTM1) null genotype in lymphocytes. Gerontology (2004) 0.75
Comparison of platelet fibronectin, ADP-induced platelet aggregation and serum total nitric oxide (NOx) levels in angiographically determined coronary artery disease. Thromb Res (2006) 0.75
Looking for Our Ten Years Results for Coronary Heart Disease and Ischemic Stroke Group for the Standpoint of Haemostasis. Turk J Haematol (2002) 0.75